Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes

Journal of Neuroinflammation

Volumn 12, Issue 1, 2015, Pages

  Zhang, Yuan ^a   Zhu, Tiebing ^b   Zhang, Xiaotian ^a   Chao, Jie ^a   Hu, Gang ^c   Yao, Honghong ^a,d  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d SOUTHEAST UNIVERSITY   (China)

Author keywords

Activation; C6 astroglia like cells; HMGB1; Methamphetamine; Migration

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; RED FLUORESCENT PROTEIN; SIGMA 1 OPIATE RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; DOPAMINE RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; ETHYLENEDIAMINE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; NITRILE;

ANIMAL CELL; ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL MOTION; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TIME FACTOR; TRANSFORMED CELL LINE;

ANIMALS; ASTROCYTES; BUTADIENES; CELL LINE, TRANSFORMED; CELL MOVEMENT; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ETHYLENEDIAMINES; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HMGB1 PROTEIN; HUMANS; METHAMPHETAMINE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; NITRILES; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84940926259     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0374-9     Document Type: Article

References (44)

1. Schepers RJ, Oyler JM, Joseph Jr RE, Cone EJ, Moolchan ET, Huestis MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003;49(1):121-32.
2. Kaushal N, Matsumoto RR. Role of sigma receptors in methamphetamine-induced neurotoxicity. Curr Neuropharmacol. 2011;9(1):54-7. doi: 10.2174/157015911795016930 .
3. Zhang Y, Lv X, Bai Y, Zhu X, Wu X, Chao J, et al. Involvement of sigma-1 receptor in astrocyte activation induced by methamphetamine via up-regulation of its own expression. J Neuroinflammation. 2015;12(1):250. doi: 10.1186/s12974-015-0250-7 .
4. Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, et al. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Exp Neurol. 2014;254:180-9. doi: 10.1016/j.expneurol.2014.01.020 .
5. Shirakawa H, Sakimoto S, Nakao K, Sugishita A, Konno M, Iida S, et al. Transient receptor potential canonical 3 (TRPC3) mediates thrombin-induced astrocyte activation and upregulates its own expression in cortical astrocytes. J Neurosci. 2010;30(39):13116-29. doi: 10.1523/JNEUROSCI.1890-10.2010 .
6. Williams A, Piaton G, Lubetzki C. Astrocytes-friends or foes in multiple sclerosis? Glia. 2007;55(13):1300-12. doi: 10.1002/glia.20546 .
7. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci. 2007;10(11):1369-76. doi: 10.1038/nn2003 .
8. Dong Y, Benveniste EN. Immune function of astrocytes. Glia. 2001;36(2):180-90. doi: 10.1002/glia.1107 .
9. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32(12):638-47. doi: 10.1016/j.tins.2009.08.002 .
10. Nair A, Frederick TJ, Miller SD. Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci. 2008;65(17):2702-20. doi: 10.1007/s00018-008-8059-5 .
11. Yan Y, Ding X, Li K, Ciric B, Wu S, Xu H, et al. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol Ther. 2012;20(7):1338-48. doi: 10.1038/mt.2012.12 .
12. Aschner M. Immune and inflammatory responses in the CNS: modulation by astrocytes. Toxicol Lett. 1998;102-103:283-7.
13. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007;28(3):138-45. doi: 10.1016/j.it.2007.01.005 .
14. Pu C, Vorhees CV. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res Dev Brain Res. 1993;72(2):325-8.
15. Shah A, Kumar S, Simon SD, Singh DP, Kumar A. HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1. Cell Death Dis. 2013;4:e850. doi: 10.1038/cddis.2013.374 .
16. Shah A, Silverstein PS, Singh DP, Kumar A. Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-kappaB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. J Neuroinflammation. 2012;9:52. doi: 10.1186/1742-2094-9-52 .
17. Sharkey J, Glen KA, Wolfe S, Kuhar MJ. Cocaine binding at sigma receptors. Eur J Pharmacol. 1988;149(1-2):171-4. 0014-2999(88)90058-1.
18. Su TP, London ED, Jaffe JH. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science. 1988;240(4849):219-21.
19. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999;19(8):5237-46.
20. Yang H, Wang H, Czura CJ, Tracey KJ. The cytokine activity of HMGB1. J Leukoc Biol. 2005;78(1):1-8. doi: 10.1189/jlb.1104648 .
21. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81(1):1-5. doi: 10.1189/jlb.0306164 .
22. Zhang J, Liu C, Hou R. Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells. Chin J Cancer Res. 2014;26(6):658-68. doi: 10.3978/j.issn.1000-9604.2014.12.05 .
23. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci. 2006;26(24):6413-21. doi: 10.1523/JNEUROSCI.3815-05.2006 .
24. Hayakawa K, Pham LD, Katusic ZS, Arai K, Lo EH. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A. 2012;109(19):7505-10. doi: 10.1073/pnas.1121146109 .
25. Hayakawa K, Miyamoto N, Seo JH, Pham LD, Kim KW, Lo EH, et al. High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter. J Neurochem. 2012. doi: 10.1111/jnc.12120 .
26. Hayakawa K, Pham LD, Arai K, Lo EH. Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB1 and beta-2 integrin signaling. Stem Cell Res. 2014;12(2):531-8. doi: 10.1016/j.scr.2013.12.008 .
27. Carlson MA, Longaker MT, Thompson JS. Modulation of FAK, Akt, and p53 by stress release of the fibroblast-populated collagen matrix. J Surg Res. 2004;120(2):171-7. doi: 10.1016/j.jss.2003.12.002 .
28. Ding N, Zhang Y, Loughran PA, Wang Q, Tsung A, Billiar TR. TIFA upregulation after hypoxia-reoxygenation is TLR4- and MyD88-dependent and associated with HMGB1 upregulation and release. Free Radic Biol Med. 2013;63:361-7. doi: 10.1016/j.freeradbiomed.2013.05.029 .
29. Huang W, Liu Y, Li L, Zhang R, Liu W, Wu J, et al. HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways. Inflammation. 2012;35(1):350-62. doi: 10.1007/s10753-011-9325-5 .
30. Cao G, Zhu J, Zhong Q, Shi C, Dang Y, Han W, et al. Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex. Neuropharmacology. 2013;67:144-54. doi: 10.1016/j.neuropharm.2012.10.020 .
31. Li Y, Hu Z, Chen B, Bu Q, Lu W, Deng Y, et al. Taurine attenuates methamphetamine-induced autophagy and apoptosis in PC12 cells through mTOR signaling pathway. Toxicol Lett. 2012;215(1):1-7. doi: 10.1016/j.toxlet.2012.09.019 .
32. Zhao N, Chen Y, Zhu J, Wang L, Cao G, Dang Y, et al. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice. Neuroscience. 2014;258:101-10. doi: 10.1016/j.neuroscience.2013.11.025 .
33. Hayakawa K, Arai K, Lo EH. Role of ERK map kinase and CRM1 in IL-1beta-stimulated release of HMGB1 from cortical astrocytes. Glia. 2010;58(8):1007-15. doi: 10.1002/glia.20982 .
34. Ding N, Wang F, Xiao H, Xu L, She S. Mechanical ventilation enhances HMGB1 expression in an LPS-induced lung injury model. PLoS One. 2013;8(9):e74633. doi: 10.1371/journal.pone.0074633 .
35. Aradhya S, Nelson DL. NF-kappaB signaling and human disease. Curr Opin Genet Dev. 2001;11(3):300-6. S0959-437X(00)00194-5.
36. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7-11. doi: 10.1172/JCI11830 .
37. Baldwin Jr AS. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest. 2001;107(1):3-6. doi: 10.1172/JCI11891 .
38. Lee CC, Wang CN, Lee YL, Tsai YR, Liu JJ. High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of mmp-9. PLoS One. 2015;10(2):e0116393. doi: 10.1371/journal.pone.0116393 .
39. Kim H, Lee S, Park HC, Lee WH, Lee MS, Suk K. Modulation of glial and neuronal migration by lipocalin-2 in zebrafish. Immune Netw. 2011;11(6):342-7. doi: 10.4110/in.2011.11.6.342 .
40. Wang HL, Peng LP, Chen WJ, Tang SH, Sun BZ, Wang CL, et al. HMGB1 enhances smooth muscle cell proliferation and migration in pulmonary artery remodeling. Int J Clin Exp Pathol. 2014;7(7):3836-44.
41. Nehil M, Paquette J, Tokuyasu T, McCormick F. High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A. Oncogene. 2014;33(44):5151-62. doi: 10.1038/onc.2013.459 .
42. Zuo Z, Che X, Wang Y, Li B, Li J, Dai W, et al. High mobility group box-1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression. Oncotarget. 2014;5(17):7458-70. 2150.
43. Chen RC, Yi PP, Zhou RR, Xiao MF, Huang ZB, Tang DL, et al. The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines. Mol Cell Biochem. 2014;390(1-2):271-80. doi: 10.1007/s11010-014-1978-6 .
44. Kim SW, Lim CM, Kim JB, Shin JH, Lee S, Lee M, et al. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway. Neurotox Res. 2011;20(2):159-69. doi: 10.1007/s12640-010-9231-x .